Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age
Clinical trial NCT06641180 · COMPLETED
Trial details
- NCT number
- NCT06641180
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-04
- Primary completion
- 2025-01-28
- Enrollment
- 1180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.